Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

(2018) Sam Jackson et al.   VACCINE

The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience

(2017) Caroline Van Den Ende et al.   Expert Review of Vaccines

Factors influencing immunologic response to hepatitis B vaccine in adults

(2016) Shigui Yang et al.   Scientific Reports

Hepatitis B Virus Infection, MicroRNAs and Liver Disease

(2015) Neelakshi Sarkar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

(2015) Daniel Shouval et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

(2015) Olivier Van Der Meeren et al.   Human Vaccines & Immunotherapeutics

Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities

(2011) Rania A. Tohme et al.   VACCINE

Compliance With Multiple-Dose Vaccine Schedules Among Older Children, Adolescents, and Adults: Results From a Vaccine Safety Datalink Study

(2009) Jennifer C. Nelson et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen

(2009) Ulla B Hellström et al.   Virology Journal